Oppenheimer analyst Rohit Vanjani reiterated an Outperform rating and $60 price target on OvaScience (NASDAQ: OVAS) following positive UAE feedback ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE